Ready-to-use, fast, consistent and automated algorithm for clinical decision support
An intelligent and advanced digital pathology solution requires image analysis tools that empower pathologists to confidently and objectively assess whole tissue slide images. The uPath HER2 (4B5) image analysis for Breast algorithm is intended for use as an aid to the pathologist in the semi-quantitative detection of HER2 protein in formalin-fixed, paraffin-embedded neoplastic breast tissue. When used with the VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody, it is indicated for use as an aid in the assessment of breast cancer patients for whom Herceptin® (trastuzumab), KADCYLA® (ado-trastuzumab emtansine) or PERJETA® (pertuzumab) treatments are being considered.
Validated for use with the VENTANA HER2 (4B5) assay for use within Roche uPath enterprise software.
Pathologist-trained artifical intelligence algorithm for cellular image analysis.
Actionable assessment of scanned slide images that are objective and reproducible, aiding in informing on potential treatment strategies.
CE-IVD marked. For Research Use Only in the US.